Table 2.
QoL measure | Univariate analysesa | Multivariate analysesa,b | ||||
---|---|---|---|---|---|---|
HRc | 95% CI | p value | HRb | 95% CI | p value | |
Cough VAS | 1.02 | (0.97–1.07) | 0.3999 | 1.01 | (0.96–1.07) | 0.7586 |
EQ-5D VAS score | 0.90 | (0.83–0.99) | 0.0031 | 0.96 | (0.88–1.05) | 0.3764 |
SGRQ total score | 1.14 | (1.05–1.23) | 0.0003 | 1.12 | (1.04–1.21) | 0.0042 |
SGRQ impact score | 1.10 | (1.03–1.17) | 0.0013 | 1.09 | (1.03–1.17) | 0.0115 |
SGRQ activity score | 1.08 | (1.02–1.15) | 0.0083 | 1.06 | (0.99–1.12) | 0.0675 |
SGRQ symptoms score | 1.11 | (1.04–1.19) | 0.0003 | 1.10 | (1.03–1.17) | 0.0037 |
CI, confidence interval; DLco, diffusing capacity of the lungs for carbon monoxide; EQ-5D, EuroQoL-5 dimensions Health Questionnaire; FVC, forced vital capacity; HR, hazard ratio; QoL, quality of life; SGRQ, St. George’s Respiratory Questionnaire; VAS, visual analogue scale
aData were considered missing at random and multiple imputations were performed
bMultivariate analyses adjusted for age, sex, percent predicted FVC, percent predicted DLco, smoking status and supplementary oxygen use at baseline
cHR for every five-point increase in scores